HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20%
HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20%
Approved
Approval ID
89036512-64f6-224b-e053-2a95a90a8068
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 16, 2019
Manufacturers
FDA
Sincerus Florida, LLC
DUNS: 080105003
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20%
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72934-2097
Product Classification
G
Generic Name
HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20%
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 16, 2019
FDA Product Classification
INGREDIENTS (3)
UREAActive
Quantity: 20 g in 100 g
Code: 8W8T17847W
Classification: ACTIB
TACROLIMUSActive
Quantity: 0.1 g in 100 g
Code: WM0HAQ4WNM
Classification: ACTIM
HYALURONATE SODIUMActive
Quantity: 1 g in 100 g
Code: YSE9PPT4TH
Classification: ACTIB